← Cancer Research Communications
Papers in Cancer Research Communications
Page 13 · newest first
- Low-dose Paclitaxel with Pembrolizumab Enhances Clinical and Immunologic Responses in Platinum-refractory Urothelial CarcinomaCancer Research Communications · 2024
- Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor–positive Breast CancerCancer Research Communications · 2024
- NRF2 Activation in Trp53;p16-deficient Mice Drives Oral Squamous Cell CarcinomaCancer Research Communications · 2024
- Exhausted Tumor-infiltrating CD39+CD103+ CD8+ T Cells Unveil Potential for Increased Survival in Human Pancreatic CancerCancer Research Communications · 2024
- INHBA is Enriched in HPV-negative Oropharyngeal Squamous Cell Carcinoma and Promotes Cancer ProgressionCancer Research Communications · 2024
- Identification and Characterization of a Small Molecule Bcl-2 Functional ConverterCancer Research Communications · 2024
- Genomic Characterization and Clinical Outcomes of Patients with Peritoneal Metastases from the AACR GENIE Biopharma Collaborative Colorectal Cancer RegistryCancer Research Communications · 2024
- Lingual Denervation Improves the Efficacy of Anti-PD-1 Immunotherapy in Oral Squamous Cell Carcinomas by Downregulating TGFβ SignalingCancer Research Communications · 2024
- Discovery and Preclinical Activity of BMS-986351, an Antibody to SIRPα That Enhances Macrophage-mediated Tumor Phagocytosis When Combined with Opsonizing AntibodiesCancer Research Communications · 2024
- Anti-Vα24Jα18 TCR Antibody Tunes iNKT Cell Responses to Target and Kill CD1d-negative Tumors in an FcγRII (CD32)-dependent MannerCancer Research Communications · 2024
- Antibody–Drug Conjugate αEGFR-E-P125A Reduces Triple-negative Breast Cancer Vasculogenic Mimicry, Motility, and Metastasis through Inhibition of EGFR, Integrin, and FAK/STAT3 SignalingCancer Research Communications · 2024
- Natural History of Germline BRCA1 Mutated and BRCA Wild-type Triple-negative Breast CancerCancer Research Communications · 2024
- Single-cell Multiomics Analysis of Myelodysplastic Syndromes and Clinical Response to Hypomethylating TherapyCancer Research Communications · 2024
- Pim Kinase Inhibitors Increase Gilteritinib Cytotoxicity in FLT3-ITD Acute Myeloid Leukemia Through GSK-3β Activation and c-Myc and Mcl-1 Proteasomal DegradationCancer Research Communications · 2024
- HDAC Inhibition Induces CD26 Expression on Multiple Myeloma Cells via the c-Myc/Sp1-mediated Promoter ActivationCancer Research Communications · 2024
- Real-world Trends, Rural-urban Differences, and Socioeconomic Disparities in Utilization of Narrow versus Broad Next-generation Sequencing PanelsCancer Research Communications · 2024
- Functional Heterogeneity in MET Pathway Activation in PDX Models of Osimertinib-resistant EGFR-driven Lung CancerCancer Research Communications · 2024
- FPFT-2216, a Novel Anti-lymphoma Compound, Induces Simultaneous Degradation of IKZF1/3 and CK1α to Activate p53 and Inhibit NFκB SignalingCancer Research Communications · 2024
- EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell CarcinomasCancer Research Communications · 2024
- A Bioinformatics Tool for Identifying Intratumoral Microbes from the ORIEN DatasetCancer Research Communications · 2024
- Lung Fibroblasts Take up Breast Cancer Cell-derived Extracellular Vesicles Partially Through MEK2-dependent MacropinocytosisCancer Research Communications · 2024
- Aberrant Upregulation of RUNX3 Activates Developmental Genes to Drive Metastasis in Gastric CancerCancer Research Communications · 2024
- Dietary Folate and Cofactors Accelerate Age-dependent p16 Epimutation to Promote Intestinal TumorigenesisCancer Research Communications · 2024
- Exploring Co-occurring POLE Exonuclease and Non-exonuclease Domain Mutations and Their Impact on Tumor MutagenicityCancer Research Communications · 2024
- A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read SequencingCancer Research Communications · 2024
- The Oncolytic Activity of Zika Viral Therapy in Human Neuroblastoma In Vivo Models Confers a Major Survival Advantage in a CD24-dependent MannerCancer Research Communications · 2024
- Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction CancerCancer Research Communications · 2024
- Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer CohortCancer Research Communications · 2024
- Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress ResponsesCancer Research Communications · 2024
- Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory Breast Cancer–Treated with Neoadjuvant Systemic TherapyCancer Research Communications · 2023
- Differential Regulation of the STING Pathway in Human Papillomavirus–Positive and -Negative Head and Neck CancersCancer Research Communications · 2023
- The ncBAF Complex Regulates Transcription in AML Through H3K27ac Sensing by BRD9Cancer Research Communications · 2023
- Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid MalignanciesCancer Research Communications · 2023
- Weakly Supervised Deep Learning Predicts Immunotherapy Response in Solid Tumors Based on PD-L1 ExpressionCancer Research Communications · 2023
- WNT4 Regulates Cellular Metabolism via Intracellular Activity at the Mitochondria in Breast and Gynecologic CancersCancer Research Communications · 2023
- FASN Gene Methylation is Associated with Fatty Acid Synthase Expression and Clinical-genomic Features of Prostate CancerCancer Research Communications · 2023
- Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical TrialsCancer Research Communications · 2023
- Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United StatesCancer Research Communications · 2023
- Sustained Disease Control in Immune Checkpoint Blockade Responders with Microsatellite Instability-high Colorectal Cancer after Treatment TerminationCancer Research Communications · 2023
- Signaling Pathway Alterations Driven by BRCA1 and BRCA2 Germline Mutations are Sufficient to Initiate Breast Tumorigenesis by the PIK3CAH1047R OncogeneCancer Research Communications · 2023
- A Randomized Phase III Study of Arfolitixorin versus Leucovorin with 5-Fluorouracil, Oxaliplatin, and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer: The AGENT TrialCancer Research Communications · 2023
- Combined Inhibition of EZH2 and FGFR is Synergistic in BAP1-deficient Malignant MesotheliomaCancer Research Communications · 2023
- A Systems Biology Approach to Understand the Racial Disparities in Colorectal CancerCancer Research Communications · 2023
- Discovery of KRB-456, a KRAS G12D Switch-I/II Allosteric Pocket Binder That Inhibits the Growth of Pancreatic Cancer Patient-derived TumorsCancer Research Communications · 2023
- p53R245W Mutation Fuels Cancer Initiation and Metastases in NASH-driven Liver TumorigenesisCancer Research Communications · 2023
- Inhibition of PRL2 Upregulates PTEN and Attenuates Tumor Growth in Tp53 -deficient Sarcoma and Lymphoma Mouse ModelsCancer Research Communications · 2023
- SHP2 Inhibition with TNO155 Increases Efficacy and Overcomes Resistance of ALK Inhibitors in NeuroblastomaCancer Research Communications · 2023
- Immunologic Signatures of Peripheral Blood T Cells Reveal the Outcome of p53MVA Vaccine and Pembrolizumab Treatment in Patients with Advanced Ovarian CancerCancer Research Communications · 2023
- FBXW7 -loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic CatastropheCancer Research Communications · 2023
- Clinical Outcomes and Evolution of Clonal Hematopoiesis in Patients with Newly Diagnosed Multiple MyelomaCancer Research Communications · 2023